Company: ZCARW
Filing Date: 2025-03-28
Form Type: DRS
Source: 0001013762-25-003498
Chunk: 6

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-03-28
Form: DRS
Chunk 6
---
 and outstanding was automatically converted into one (1) share of Common Stock, without any change in the par value per share.
In addition, (i) a proportionate adjustment was made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options and warrants to purchase shares of Common Stock, and (ii) the number of shares reserved for issuance pursuant to the Company’s equity incentive plans was also reduced proportionately. Any fraction of a share of Common Stock that would have been created as a result of the Reverse Stock Split was rounded up to the nearest whole share. Except as otherwise indicated, all share and per share information in this prospectus gives effect to both of the Reverse Stock Splits at a cumulative ratio of 1-for-2,000.

We are an “emerging
growth company,” as defined under the federal securities laws and, as such, we have elected to comply with certain reduced public
company reporting requirements for this prospectus and future filings. See “Prospectus Summary - Emerging Growth Company.”

This offering will terminate
on , 2025, unless we decide to terminate the offering (which we may do at any time in our
discretion) prior to such date.

Investing in our securities involves risks. See “ Risk Factors” beginning on page 15 of this prospectus and elsewhere in this prospectus for a discussion of information that should be considered in connection with an investment in our securities.

|                                           |     | Per Unit |     | Per        
 Pre-Funded 
 Unit       |     | Total |
|:------------------------------------------|:----|:---------|:----|:-----------|:----|:------|
| Public offering price                     |     | $        |     | $          |     | $     |
| Underwriting discounts and commissions(1) |     | $        |     | $          |     | $     |
| Proceeds to us (before expenses)          |     | $        |     | $          |     | $     |

| (1) | The underwriter will receive an                                                                                                         
 underwriting discount equal to 8.0% of the gross proceeds from the sale of securities in the offering. We have also agreed to reimburse 
 the underwriter for certain expenses in connection with this offering. See “Underwriting” for additional information regarding          
 total underwriting compensation, including information on underwriting discounts and offering expenses.                                 |

We have granted the underwriter
an option exercisable within 45